| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0123c1dfd65caa2cf0e4ad7ebf33491 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2014-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_648f18a021c7e73acabe400b10963b3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_247508940eec30039438ed3333a17233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e21d8e0cac6d036044d8a608253a4d98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_103e646e7b05c5c2be6dc182ebdc06fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cc040e0843ca495a9a24dd8d8b6e844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de2e530f20a8f7a987c2b47776acf5e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebc9d7a6fa8ab9455ac4b6604b696666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dc866e2b6597b12871ed9e920cc7418 |
| publicationDate |
2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-371108-B |
| titleOfInvention |
PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INITIATORS. |
| abstract |
The present invention relates to compounds that are useful as inhibitors of Wee-1 kinase activity. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer. |
| priorityDate |
2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |